当前位置: X-MOL 学术JAMA Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The Bitter, Expensive Pill at the End of Life
JAMA Oncology ( IF 22.5 ) Pub Date : 2017-11-01 , DOI: 10.1001/jamaoncol.2017.1650
Marc De Hert 1 , Wim Distelmans 2
Affiliation  

To the Editor With initial amazement we read the recent Viewpoint of Shankaran et al.1 The practice of “Big Pharma” to scam patients at one of the most vulnerable moments of their lives with excessive drug cost is far from dignified.

Over the years, the practice of euthanasia and/or physician-assisted death has been confronted with fierce opposition. But even the most creative critics using different formats of the “slippery slope” argument would never have come up with the intolerable practices of pharmaceutical firms.2,3



中文翻译:

生命尽头的苦涩而昂贵的药

致编辑最初感到惊讶的是,我们阅读了Shankaran等人的最新观点。1 “大药房”的做法是在患者生命中最脆弱的时刻之一,以高昂的药物费用欺骗他们,这远非端庄。

多年来,安乐死和/或医生协助死亡的做法遭到了激烈的反对。但是,即使是最有创造力的批评家也使用不同形式的“滑坡”论据,也永远不会想出制药公司令人无法忍受的做法。2 ,3-

更新日期:2017-11-10
down
wechat
bug